Kalfoglou A L, Scott J, Hudson K
Department of Sociology and Anthropology, University of Maryland, Baltimore County, Baltimore, MD 21250, USA.
Hum Reprod. 2008 Dec;23(12):2731-6. doi: 10.1093/humrep/den329. Epub 2008 Sep 1.
MicroSort, a sperm-sorting technology for sex selection, may eventually be approved by the Food and Drug Administration and marketed to the public. Data on US public attitudes about the morally appropriate uses and regulation of this technology are lacking.
We conducted 20 focus groups in April 2003 with participants from five major US cities to identify the values that shape Americans' attitudes about the use and regulation of preconception sex selection (PSS) technology. One hundred and seventy-six individuals between the ages of 18 and 68 were assigned to groups ranging from 6 to 11 participants based on their location, sex, race/ethnicity, religion, age, education and parental status. Qualitative analysis of focus group transcripts was conducted using NVivo 2.0 software to determine beliefs and values that shape participants' opinions about the appropriate use and regulation of PSS.
Most participants strongly favor using PSS to avoid X-linked genetic diseases. Although some participants were uncomfortable with the use of PSS for non-medical sex selection, believing it to be 'selfish' and inconsistent with parental love, they did not perceive the potential harms to be significant enough to warrant governmental intrusion into reproductive decisions.
PSS should face little public opposition in the US if widely marketed.
MicroSort是一种用于性别选择的精子分选技术,最终可能会获得美国食品药品监督管理局的批准并向公众销售。目前缺乏关于美国公众对该技术在道德上适当使用和监管态度的数据。
2003年4月,我们在美国五个主要城市组织了20个焦点小组,参与者来自不同群体,目的是确定影响美国人对孕前性别选择(PSS)技术使用和监管态度的价值观。176名年龄在18至68岁之间的个体,根据其所在位置、性别、种族/民族、宗教、年龄、教育程度和父母身份,被分成6至11人的小组。使用NVivo 2.0软件对焦点小组的文字记录进行定性分析,以确定影响参与者对PSS适当使用和监管意见的信念和价值观。
大多数参与者强烈支持使用PSS来避免X连锁遗传病。尽管一些参与者对将PSS用于非医疗目的的性别选择感到不安,认为这是“自私的”,且与父母之爱相悖,但他们认为潜在危害不足以严重到需要政府干预生育决策。
如果广泛推广,PSS在美国应该不会面临太多公众反对。